celecoxib 200 MG Oral Capsule [Celebrex]

RxCUI: 213469
RxNorm name: celecoxib 200 MG Oral Capsule [Celebrex]
Display name: CeleBREX (Oral Pill)
Full name: celecoxib 200 MG Oral Capsule [Celebrex]
Term type: SBD
Status: Active
Strength: 200 mg
Dose form: Cap
Route: Oral Pill
Updated: 2026-11-14 08:24:41

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 042005
Active start: 042005
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
celecoxib	200 MG / 1 EACH	celecoxib	celecoxib

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Capsule	316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
celecoxib	140587

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	CeleBREX 200 MG Oral Capsule	1	NAMES
RxNorm Name	celecoxib 200 MG Oral Capsule [Celebrex]	1	NAMES
RxNorm Synonym	Celebrex 200 MG Oral Capsule	1	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	2 linked values 2d6675e4-5859-4be2-8037-a20ce9f707aa 814511c9-89ef-42d7-912e-c00147833b7e	2	CODES
RxCUI	213469	1	CODES
MMSL_CODE	BD6865	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
58151-084-01	58151-084	CELEBREX Celecoxib	Viatris Specialty LLC	NDA020998
58151-084-05	58151-084	CELEBREX Celecoxib	Viatris Specialty LLC	NDA020998
58151-084-88	58151-084	CELEBREX Celecoxib	Viatris Specialty LLC	NDA020998

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
NDA020998	58151-084	CELEBREX Celecoxib	NDA	Viatris Specialty LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 3 of 3 · 264 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
66267004894	rxnav_historical
66336072710	rxnav_historical
66336072714	rxnav_historical
66336072715	rxnav_historical
66336072720	rxnav_historical
66336072760	rxnav_historical
66336072790	rxnav_historical
66411052510	rxnav_historical
66411052530	rxnav_historical
67544020430	rxnav_historical
67801032903	rxnav_historical
67801032935	rxnav_historical
68115007000	rxnav_historical
68115007007	rxnav_historical
68115007010	rxnav_historical
68115007014	rxnav_historical
68115007015	rxnav_historical
68115007020	rxnav_historical
68115007030	rxnav_historical
68115007060	rxnav_historical
68387055215	rxnav_historical
68387055230	rxnav_historical
68387055260	rxnav_historical
68788076803	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CELEBREX	CELECOXIB	Viatris Specialty LLC	2d6675e4-5859-4be2-8037-a20ce9f707aa	2024-11-22	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 58151-084-01 ndc (package): 58151-084-05 ndc (package): 58151-084-88 ndc (product): 58151-084 ndc11 (package): 58151008401 ndc11 (package): 58151008405 ndc11 (package): 58151008488 rxcui: 213469

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2d6675e4-5859-4be2-8037-a20ce9f707aa	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	13	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998	20241122
73eb9256-dcda-4eb1-8a6e-700522146f2e	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	5	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20150505
925b0408-2ba4-4d4c-a1cd-ddfa7115234d	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20120127
b6bd0101-ebf0-43e8-99bf-21cb032b05d6	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20111214
05cf80f2-12a0-46b0-bcb7-1c982ed7bd3e	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	2	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20140703
e3591a83-fbb4-4679-89f0-ce3a2331ed54	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	2	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20110513
e082d783-793f-4c17-b124-04fe377fb272	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20140820
814511c9-89ef-42d7-912e-c00147833b7e	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20120912
bff7e0aa-0c01-4f6e-89ed-da27cc36706e	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20110606
14e50e10-bbe0-4a2c-983a-19bfa79bdef7	CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	20090710

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
f2f090c2-3ee1-7689-e053-2995a90abe38	These highlights do not include all the information needed to use LEVOFLOXACIN TABLETS safely and effectively. See full prescribing information for LEVOFLOXACIN TABLETS. LEVOFLOXACIN tablets, for oral use Initial U.S. Approval: 1996	Northwind Health Company, LLC	20260101
a6854053-029c-419f-8c79-8b59a2600fa1	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998	PD-Rx Pharmaceuticals, Inc.	20220311
8d52185d-421f-4e34-8db7-f7676db2a226	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998	PFIZER LABORATORIES DIV PFIZER INC	20210415
9f9dd7b9-a072-46d0-a8b5-b3e138c85f1c	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	Proficient Rx LP	20210101
a645dfcd-7343-4c79-af8b-1117e4a5b113	CELEBREX	Direct Rx	20191014
fe16ecb3-621c-4dbb-92e6-9e636b75ab84	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	Cardinal Health	20150428
e082d783-793f-4c17-b124-04fe377fb272	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	Preferred Pharmaceuticals, Inc.	20140820
906d08ee-cf5b-41f7-b2d4-73179f7d74f0		National Council for Prescription Drug Programs	20130213
c1bc6c14-bc07-4dce-8b1d-fd9db891244f		National Council for Prescription Drug Programs	20120724
b6e129fd-3d10-4038-b267-f9383b6a4c84		National Council for Prescription Drug Programs	20120724
c21b0501-da1a-438b-9afb-ad818c17ce6f		National Council for Prescription Drug Programs	20120724
c48b96dc-21f9-48d5-bf5f-69781d33cfcb		National Council for Prescription Drug Programs	20120724
cccc9f59-6a98-4cc0-bc36-2a84ccf0754e		National Council for Prescription Drug Programs	20120724
da3a2edb-5542-4bff-8718-58ea39d0d34f		National Council for Prescription Drug Programs	20120724
e84eaf7b-51ec-4744-87d1-0a3393cc878c		National Council for Prescription Drug Programs	20120724
ec748824-16e5-4ef9-978d-a8d51b192215		National Council for Prescription Drug Programs	20120724
f33effac-8d1b-48da-bebf-b6a0e2c0ac60		National Council for Prescription Drug Programs	20120724
f391c515-541e-4a7f-8857-65a8bfdd483a		National Council for Prescription Drug Programs	20120724
f8a4d297-7820-48d0-9cf7-c0247ec534ed		National Council for Prescription Drug Programs	20120724
f9ee868f-1221-42cf-98fd-25e70adf531c		National Council for Prescription Drug Programs	20120724
fc0eef74-893c-43b6-8f5d-83ac8090bdc4		National Council for Prescription Drug Programs	20120724
fffda792-18ff-470c-aeb6-d0481c2fe9d8		National Council for Prescription Drug Programs	20120724
a1df2611-e6a3-4770-8bd6-a853cb04ae4a		National Council for Prescription Drug Programs	20120724
8b7d24e6-0730-4777-8e8b-c801c5b2ec2f		National Council for Prescription Drug Programs	20120724
8e11492f-e981-463b-afe2-3dc5b8382e1e		National Council for Prescription Drug Programs	20120724
901bdc30-b797-47c0-93d6-9bd65289a5a4		National Council for Prescription Drug Programs	20120724
93519f0f-867e-4d6d-9d07-999375b0f5cb		National Council for Prescription Drug Programs	20120724
935ae5a2-d228-48bd-adc8-78802a8dfef5		National Council for Prescription Drug Programs	20120724
9a35d96a-5aa3-4efe-95f9-39bcb79a2cac		National Council for Prescription Drug Programs	20120724
9eb4d7e9-2fc2-420f-b8ed-7013d691a67f		National Council for Prescription Drug Programs	20120724
a4121ee1-ebc7-4fbc-a91d-a6d2081d51a6		National Council for Prescription Drug Programs	20120724
a6132694-1737-4d59-9474-31d11ecbffb1		National Council for Prescription Drug Programs	20120724
ad6d289a-741e-406e-94bd-272a870363c5		National Council for Prescription Drug Programs	20120724
b2e1b572-c51e-4162-aa4b-d45a5be07132		National Council for Prescription Drug Programs	20120724
88690826-0cc7-4b18-8d5f-b8516429c248		National Council for Prescription Drug Programs	20120724
bbee4223-9481-42d2-821c-bbc71b56f1d0		National Council for Prescription Drug Programs	20120724
925b0408-2ba4-4d4c-a1cd-ddfa7115234d	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	STAT Rx USA LLC \| PSS World Medical Inc	20120127
b6bd0101-ebf0-43e8-99bf-21cb032b05d6	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	H.J. Harkins Company, Inc. \| G.D. Searle LLC Division of Pfizer Inc \| Pfizer Pharmaceuticals LLC \| Pfizer Asia Pacific PTE LTD	20111214
bff7e0aa-0c01-4f6e-89ed-da27cc36706e	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	Keltman Pharmaceuticals Inc.	20110606
e3591a83-fbb4-4679-89f0-ce3a2331ed54	These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998	STAT RX USA LLC	20110513

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	M01AH	Coxibs	ATC1-4		celecoxib
ATC	L01XX	Other antineoplastic agents	ATC1-4		celecoxib
FDASPL	N0000175722	Nonsteroidal Anti-inflammatory Drug	EPC	has_epc	celecoxib
FDASPL	N0000000160	Cyclooxygenase Inhibitors	MOA	has_moa	celecoxib
MEDRT	D000068579	Celecoxib	CHEM	has_ingredient	celecoxib
MEDRT	D011125	Adenomatous Polyposis Coli	DISEASE	may_treat	celecoxib
MEDRT	D001172	Arthritis, Rheumatoid	DISEASE	may_treat	celecoxib
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	celecoxib
MEDRT	D004412	Dysmenorrhea	DISEASE	may_treat	celecoxib
MEDRT	D010003	Osteoarthritis	DISEASE	may_treat	celecoxib
MEDRT	D011247	Pregnancy	DISEASE	ci_with	celecoxib
MEDRT	D013167	Spondylitis, Ankylosing	DISEASE	may_treat	celecoxib
MEDRT	N0000008288	Cyclooxygenase 2 Inhibitors	MOA	has_moa	celecoxib
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	celecoxib
MEDRT	N0000000045	Fecal Excretion	PK	has_pk	celecoxib
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	celecoxib
MEDRT	N0000000042	Renal Excretion	PK	has_pk	celecoxib

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Celebrex	rxnav_allrelated
DF	DF	Oral Capsule	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	celecoxib	rxnav_allrelated
SBD	SBD	celecoxib 200 MG Oral Capsule [Celebrex]	rxnav_allrelated
SBDC	SBDC	celecoxib 200 MG [Celebrex]	rxnav_allrelated
SBDF	SBDF	celecoxib Oral Capsule [Celebrex]	rxnav_allrelated
SBDG	SBDG	Celebrex Oral Product	rxnav_allrelated
SBDG	SBDG	Celebrex Pill	rxnav_allrelated
SCD	SCD	celecoxib 200 MG Oral Capsule	rxnav_allrelated
SCDC	SCDC	celecoxib 200 MG	rxnav_allrelated
SCDF	SCDF	celecoxib Oral Capsule	rxnav_allrelated
SCDG	SCDG	celecoxib Oral Product	rxnav_allrelated
SCDG	SCDG	celecoxib Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	200 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	NDA	NDA020998
NAMES	Prescribable Synonym	CeleBREX 200 MG Oral Capsule
NAMES	Tallman Synonym	CeleBREX 200 MG Oral Capsule
NAMES	Tallman Synonym	celecoxib 200 MG Oral Capsule [CeleBREX]
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon